CRON
Price
$2.51
Change
-$0.09 (-3.46%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
989.12M
64 days until earnings call
SNDL
Price
$2.48
Change
-$0.21 (-7.84%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
635.66M
76 days until earnings call
Interact to see
Advertisement

CRON vs SNDL

Header iconCRON vs SNDL Comparison
Open Charts CRON vs SNDLBanner chart's image
Cronos Group
Price$2.51
Change-$0.09 (-3.46%)
Volume$29.53K
Capitalization989.12M
SNDL
Price$2.48
Change-$0.21 (-7.84%)
Volume$18.15K
Capitalization635.66M
CRON vs SNDL Comparison Chart in %
Loading...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. SNDL commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and SNDL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (CRON: $2.60 vs. SNDL: $2.68)
Brand notoriety: CRON and SNDL are both not notable
CRON represents the Pharmaceuticals: Generic, while SNDL is part of the Beverages: Alcoholic industry
Current volume relative to the 65-day Moving Average: CRON: 234% vs. SNDL: 149%
Market capitalization -- CRON: $989.12M vs. SNDL: $635.66M
CRON [@Pharmaceuticals: Generic] is valued at $989.12M. SNDL’s [@Beverages: Alcoholic] market capitalization is $635.66M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $69.31B to $0. The market cap for tickers in the [@Beverages: Alcoholic] industry ranges from $19.33T to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B. The average market capitalization across the [@Beverages: Alcoholic] industry is $6.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 1 FA rating(s) are green whileSNDL’s FA Score has 0 green FA rating(s).

  • CRON’s FA Score: 1 green, 4 red.
  • SNDL’s FA Score: 0 green, 5 red.
According to our system of comparison, CRON is a better buy in the long-term than SNDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 4 TA indicator(s) are bullish while SNDL’s TA Score has 5 bullish TA indicator(s).

  • CRON’s TA Score: 4 bullish, 5 bearish.
  • SNDL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNDL is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SNDL (@Beverages: Alcoholic) price change was +19.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.76%. For the same industry, the average monthly price growth was +14.12%, and the average quarterly price growth was +84.21%.

The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was +0.25%. For the same industry, the average monthly price growth was +5.02%, and the average quarterly price growth was -4.74%.

Reported Earning Dates

CRON is expected to report earnings on Nov 05, 2025.

SNDL is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.76% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Beverages: Alcoholic (+0.25% weekly)

The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($989M) has a higher market cap than SNDL($636M). SNDL YTD gains are higher at: 49.721 vs. CRON (28.713). CRON has higher annual earnings (EBITDA): -25.58M vs. SNDL (-39.96M). CRON has more cash in the bank: 834M vs. SNDL (212M). CRON has less debt than SNDL: CRON (2.01M) vs SNDL (151M). SNDL has higher revenues than CRON: SNDL (944M) vs CRON (130M).
CRONSNDLCRON / SNDL
Capitalization989M636M156%
EBITDA-25.58M-39.96M64%
Gain YTD28.71349.72158%
P/E Ratio52.00N/A-
Revenue130M944M14%
Total Cash834M212M393%
Total Debt2.01M151M1%
FUNDAMENTALS RATINGS
CRON vs SNDL: Fundamental Ratings
CRON
SNDL
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9094
PRICE GROWTH RATING
1..100
4035
P/E GROWTH RATING
1..100
692
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNDL's Valuation (67) in the null industry is in the same range as CRON (69) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to CRON’s over the last 12 months.

SNDL's Profit vs Risk Rating (100) in the null industry is in the same range as CRON (100) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to CRON’s over the last 12 months.

CRON's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as SNDL (94) in the null industry. This means that CRON’s stock grew similarly to SNDL’s over the last 12 months.

SNDL's Price Growth Rating (35) in the null industry is in the same range as CRON (40) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to CRON’s over the last 12 months.

CRON's P/E Growth Rating (6) in the Pharmaceuticals Other industry is significantly better than the same rating for SNDL (92) in the null industry. This means that CRON’s stock grew significantly faster than SNDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONSNDL
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
84%
Momentum
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
78%
MACD
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
Aroon
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANTGX10.59-0.03
-0.28%
American Century Non-US Intrs Val G
WFENX14.72-0.10
-0.67%
Allspring International Equity Inst
ATECX109.18-0.80
-0.73%
AB Sustainable Global Thematic C
MCSCX11.10-0.09
-0.80%
M3Sixty Small Cap Growth
OEGNX25.58-0.35
-1.35%
Invesco Discovery Mid Cap Growth R

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
N/A
SNDL - CRON
73%
Closely correlated
-0.37%
TLRY - CRON
60%
Loosely correlated
-6.12%
OGI - CRON
59%
Loosely correlated
N/A
CGC - CRON
57%
Loosely correlated
-4.26%
ACB - CRON
55%
Loosely correlated
-3.56%
More